JSCAI Frequently Asked Questions

LAST UPDATED: January 4, 2023

The Society for Cardiovascular and Angiography Interventions (SCAI), the world-leading society for interventional and invasive cardiology, launched its scientific journal: the Journal of the Society for Cardiovascular Angiography and Interventions (JSCAI) in January of 2022.

JSCAI published its first issue on January 31, 2022.

JSCAI aims to provide the latest clinical research, first-in-human studies, and other original research on interventional therapies, diagnostic modalities, and innovations across the spectrum of ischemic heart disease, complex coronary disease, pediatric and adult congenital heart disease, structural and valvular disease, and peripheral vascular disease. It is the home for all SCAI clinical guidelines, expert consensus documents, and position statements.

JSCAI is a Gold Open Access journal, available online in partnership with Elsevier, one of the leading medical publishers in the world. 

When can I read the new journal? 

JSCAI launched in 2022. Please visit jscai.org to see the latest published articles and research.

When can I submit an article to the new journal? 

Submissions for JSCAI opened in October 2021. Submit your paper.

Will SCAI have two journals, JSCAI and CCI? 

JSCAI will be the official journal of SCAI beginning in 2022. 

What is happening to CCI? 

CCI will continue to be owned and operated by Wiley. SCAI will pay for members to have electronic access to CCI through the 2022 calendar year. All clinical documents published by SCAI in CCI will remain open access in perpetuity.  

Why is the change being made? 

Launching a new journal that is owned and managed by SCAI will enable us to drive quality, make everything accessible through Open Access, and continue to broaden the impact that our evidence-led resources provide for you, our interventional cardiologists. 

What is the purpose of the change? 

Having a journal that is owned by SCAI will enable us to focus on the issues that matter. JSCAI will have a short time to publication with your research instantly accessible to everyone upon publication. JSCAI will also be the home for all SCAI’s clinical guidelines, expert consensus documents, and position statements.

How does the change align with SCAI values?  

Owning our own journal will enable the society to drive quality, make everything accessible through Open Access, and help us to continue to broaden the impact that our evidence-led resources provide for you, our interventional cardiologists. 

What are article processing charges? 

Article processing charges (APCs) are submitted by the authors to cover the costs of publishing a manuscript.  While not inherent to Open Access publishing, most journals rely on APCs to cover the cost of editorial review and publication. APCs have been common for years in most areas of biomedical research but have been slow to arrive in cardiology. 

The APC funds can come from the sponsors or grant funders of the research, institutional funds, or other educational/research funds.  Increasingly institutions are agreeing to pay for their researchers/faculty’s APCs when research funds are not available.  

APCs will be discounted 50% for articles published in 2022, and 25% for articles published in 2023. Beginning in 2024, SCAI members will enjoy 25% discount in perpetuity. 

*Excluding Taxes

What does Gold Open Access (OA) mean? 

Gold OA makes the final version of an article freely and permanently accessible for everyone, immediately after publication. Copyright for the article is retained by the authors and most permission barriers are removed, allowing the re-use of the work as long as the authors are acknowledged and cited as they retain the copyright. An overview of fully OA journals can be found in the Directory of Open Access Journals (DOAJ).

Gold OA is the leading trend in medical publishing with many governmental agencies and academic institutions increasingly mandating OA for research findings. Most new journals are being published using the Gold OA structure, such as JAHA.

Does being Open Access mean that the standard of research isn’t as good?

Good quality OA journals have a rigorous peer review process. This means that an article’s quality, validity, and relevance has been assessed by independent peers within the field. All articles in JSCAI go through the same peer review process as other leading journals.

There are many fraudulent and predatory journals that do not provide the same quality assurance and services delivered by a reputable journal. SCAI will own and manage JSCAI, and we pride ourselves on offering a journal in which you can be proud to publish.

JSCAI meets all principles of transparency and best practice in scholarly publishing. Over the next few months, the Editorial Board will be announced, the clear conflict of interest policy will be available, and once submissions open, a clear peer review process will be operating.

Is JSCAI indexed in PubMed Central?  

JSCAI is not yet indexed in PubMed. All new journals are required to publish a certain number of peer-reviewed articles; JSCAI will begin the PMC application process in 2022.  

What types of submissions will JSCAI review?

JSCAI will peer-review Original Research, Study Designs, Meta-Analysis, Reviews, Imaging and Case Reports, Research Letters, and Letters to the Editor.  

What is “Your Paper Your Way”?  

Authors may submit a manuscript as a single Word or PDF file for initial submission.  Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article. 

For previously submitted but unpublished manuscripts, JSCAI will perform an expedited review and decision within 7 days of original research submitted with a copy of a journal rejection letter, at least 2 peer reviews with point-by-point responses, a copy of the paper with tracked changes, and a non-highlighted copy of the paper. The editors will treat the original peer review as the first review of the paper but may choose to send the paper for additional review.